Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-09-09

Clinical Trial Update: Study to Determine the Safety and Feasibility of Utilizing the CD Leycom Pressure/Conductance Catheter to Determine Optimal LV Pacing Site [Phase 1]

View source ↗

Summary

A Phase 1 study to assess the safety and feasibility of using the CD Leycom Pressure/Conductance Catheter to determine the optimal left ventricular pacing site …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Lancaster General Hospital | Conditions: Heart Failure | Phase 1 | Status: WITHDRAWN